Bergan T, Vik-Mo H, Anstad U
Clin Pharmacol Ther. 1977 Aug;22(2):211-24. doi: 10.1002/cpt1977222211.
The pharmacokinetics of a combination of sulfadiazine and trimethoprim has been studied in 16 patients with varying degrees of reduced renal function. In normal renal function, the serum half-life (t1/2) of active sulfadiazine, total sulfadiazine, and trimethoprim were quite close: 7.7, 9.6, and 12.1 hr, respectively. There was a gradual increase in serum t1/2 with reduction in renal function for both active and total sulfadiazine and for trimethoprim. With accurate determinations of endogenous renal clearance, t1/2 estimates may be made from regression curves presented. The relative distribution in the body was unrelated to renal function. It was similar for the two fractions of sulfonamide and higher for trimethoprim. The means were 0.371, 0.176, and 1.104 L/kg, respectively, for active and total sulfadiazine, and trimethoprim.
对16例肾功能不同程度减退的患者研究了磺胺嘧啶与甲氧苄啶联合用药的药代动力学。在肾功能正常时,活性磺胺嘧啶、总磺胺嘧啶和甲氧苄啶的血清半衰期(t1/2)相当接近,分别为7.7小时、9.6小时和12.1小时。随着肾功能减退,活性和总磺胺嘧啶以及甲氧苄啶的血清t1/2均逐渐增加。通过准确测定内源性肾脏清除率,可根据给出的回归曲线进行t1/2估算。药物在体内的相对分布与肾功能无关。磺胺类药物的两个组分情况相似,而甲氧苄啶的相对分布更高。活性和总磺胺嘧啶以及甲氧苄啶的均值分别为0.371L/kg、0.176L/kg和1.104L/kg。